Cart
sales@molnova.com
BET bromodomain inhibitor
CAS No. 1505453-59-7
BET bromodomain inhibitor( MDK3597 | MDK-3597 | MDK 3597 | BET bromodomain inhibitor )
Catalog No. M12098 CAS No. 1505453-59-7
It is a BET bromodomain inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 76 | In Stock |
|
| 2MG | 43 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 117 | In Stock |
|
| 25MG | 198 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 431 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBET bromodomain inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionIt is a BET bromodomain inhibitor.
-
DescriptionIt is a BET bromodomain inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsMDK3597 | MDK-3597 | MDK 3597 | BET bromodomain inhibitor
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorBET bromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1505453-59-7
-
Formula Weight400.26
-
Molecular FormulaC20H15Cl2N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(N)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C3=CC(Cl)=CC=C3C4=C1ON=C4C
-
Chemical Name(S)-2-[8-Chloro-6-(4-chloro-phenyl)-1-methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xiao Y, et al. Rheumatology (Oxford). 2015 Aug 3
molnova catalog
related products
-
JWG-071
JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.
-
Cyclogalegenol
Astramembrangenin (Cycloastragenol) is a triterpenoid saponin compound and a hydrolysis product of the main active ingredient in Astragalus membranaceus.?Cycloastragenol (CAG) may have a novel therapeutic role in depression.
-
Trotabresib
Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.
